cycloserine has been researched along with riboflavin in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (66.67) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Chibata, I; Kato, J; Uchida, T; Watanabe, T | 1 |
| Fondaminskaia, LD; Gol'dshteĭn, VD; Ioffe, RA | 1 |
1 review(s) available for cycloserine and riboflavin
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for cycloserine and riboflavin
| Article | Year |
|---|---|
Production of flavine-adenine dinucleotide from riboflavine by a mutant of Sarcina lutea.
Topics: Acetates; Adenine; Adenosine; Air; Aminohydrolases; Culture Media; Cycloserine; Fermentation; Flavin Mononucleotide; Flavin-Adenine Dinucleotide; Guanine; Hydrogen-Ion Concentration; Mutation; Penicillins; Riboflavin; Sarcina; Sodium; Streptomycin; Surface-Active Agents; Thiamine | 1974 |
[Riboflavin metabolism in pulmonary tuberculosis].
Topics: Cycloserine; Humans; Riboflavin; Tuberculosis, Pulmonary | 1967 |